Zanganeh Mahkam — SEC insider filings
SEC reporting owner CIK 1507650. 39 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2020-11-13 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 19 legs across 10 filings — 57,642,692 shares, $115,433,797 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: purchase of 3,810,000 shares @ $13.12 ($49,987,200) in Summit Therapeutics Inc., filed 2026-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer, Director, 10% owner | 25 | 19 legs · 57,642,692 sh · $115,433,797 | — | 31 |
| PULSE BIOSCIENCES, INC. (PLSE) | Director | 14 | — | — | 34 |
Insider filings — Zanganeh Mahkam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 14,504 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 3,810,000 @ $13.12 | EDGAR |
| 2026-06-04 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 100,000 @ $14.60 | EDGAR |
| 2026-01-06 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 11,232 (derivative) @ $8.76 | EDGAR |
| 2025-10-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 · Grant/award (A): 13,980,789 @ $18.74 | EDGAR |
| 2025-09-11 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07 | EDGAR |
| 2025-08-19 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 24,134 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative) | EDGAR |
| 2025-04-09 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 (derivative) @ $0 · Option exercise/expiry (X): 30,121 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 10,724 (derivative) @ $9.18 | EDGAR |
| 2024-10-03 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 315,681 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-08-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 260,000 (derivative) · Grant/award (A): 100,000 (derivative) · Grant/award (A): 2,397,640 (derivative) | EDGAR |
| 2024-08-13 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-07-09 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Option exercise/expiry (X): 60,242 · Purchase (P): 30,121 (derivative) · Purchase (P): 30,121 (derivative) | EDGAR |
| 2024-06-24 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 8,247 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 26,000 @ $3.72 · Purchase (P): 34,321 @ $3.72 · Purchase (P): 30,000 @ $3.75 · Purchase (P): 20,000 @ $3.71 | EDGAR |
| 2023-12-13 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise/expiry (X): 489,814 @ $1.44 · Purchase (P): 5,000 @ $2.07 · Option exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 489,814 (derivative) @ $0 · Option exercise/expiry (X): 315,681 (derivative) @ $0 | EDGAR |
| 2023-11-15 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 20,000 @ $2.14 · Option exercise (M): 56,075 @ $2.14 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 56,075 (derivative) @ $0 | EDGAR |
| 2023-10-16 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 11,988,198 (derivative) | EDGAR |
| 2023-07-06 | 4/A | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 86,668 @ $2.05 · Option exercise/expiry (X): 86,668 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 86,668 @ $2.05 · Option exercise/expiry (X): 86,668 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 20,168 (derivative) @ $0 | EDGAR |
| 2023-03-13 | 4/A | Summit Therapeutics Inc. (SMMT) | Purchase (P): 16,778,415 @ $1.05 · Purchase (P): 6,748,629 @ $1.05 | EDGAR |
| 2023-03-08 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 15,973,743 @ $1.05 · Purchase (P): 804,672 @ $1.05 · Purchase (P): 6,748,629 @ $1.05 | EDGAR |
| 2022-12-09 | 4 | Summit Therapeutics Inc. (SMMT) | Other (J): 373,857 | EDGAR |
| 2022-08-18 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 184,430 @ $0.97 · Purchase (P): 4,593,777 @ $0.97 · Purchase (P): 1,030,925 @ $0.97 | EDGAR |
| 2022-06-10 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 86,668 · Purchase (P): 86,668 (derivative) | EDGAR |
| 2022-05-23 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 56,075 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 15,000 (derivative) | EDGAR |
| 2021-05-21 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 8,026 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 389,077 @ $5.24 | EDGAR |
| 2021-01-21 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 3,000 @ $7.01 · Option exercise/expiry (X): 307 @ $7.01 · Option exercise/expiry (X): 3,000 (derivative) @ $0 · Option exercise/expiry (X): 307 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 2,400,000 (derivative) | EDGAR |
| 2020-11-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 200,000 (derivative) · Grant/award (A): 3,323 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1507650 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs